You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Prostate cancer discovery opens door to more tailored treatments
- 2. Prostate cancer, race and the need for tests | Letters
- 3. Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
- 4. Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- 5. Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms
- 6. Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care
- 7. IV medication could be taken orally for range of cancer, Alzheimer's treatments
- 8. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 9. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
- 10. Three-dimensional gene hubs may promote brain cancer
Last updated at 10:45 GMT
Hot News Makers
Health/Pharma Companies
-
237512.94
-
81387.77
-
34361.70
-
32449.07
-
24282.20
-
13279.20
-
7742.79
-
5876.17
-
5337.26
-
5232.17
Drugs, Treatments, Trials
-
109574.94
-
14436.40
-
13858.75
-
11537.14
-
10288.77
-
9521.54
-
6464.43
-
4775.25
-
2429.66
-
2410.63
Last updated at 10:10 GMT
